Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1995
No influence of pantoprazole on the pharmacokinetics of phenytoinM V Middle, F O Müller, R Schall, et al.
British Journal of Clinical Pharmacology|June 1, 1995
Lack of effect of pantoprazole on the pharmacodynamics and pharmacokinetics of warfarinL Duursema, F O Müller, R Schall, et al.
Clinical Pharmacology and Therapeutics|January 1, 1985
Dynamic responses to intravenous urapidil and dihydralazine in normal subjectsG G Belz, J H Matthews, D Graf, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1996
No influence of pantoprazole on the pharmacokinetics of phenytoinM V Middle, F O Müller, R Schall, et al.
Pneumologie (Stuttgart, Germany)|September 17, 1998
[Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma]D Ukena, U Harnest, R Sakalauskas, et al.
The European Respiratory Journal|March 11, 1998
Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthmaD Ukena, U Harnest, R Sakalauskas, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 1, 1995
Relative bioavailability of different valproic acid formulationsG Franke, E Diletti, C Hoffmann, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 1, 1987
Comparative bio-availability of theophylline whole and halved sustained-release tabletsF O Müller, H K Hundt, H G Luus, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 1996
Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjectsS Crescioli, A Dal Carobbo, P Maestrelli, et al.
Pneumologie (Stuttgart, Germany)|November 1, 1991
[24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration]G E D'Alonzo, M H Smolensky, S Feldman, et al.
Pageof 11